Overall, our findings support the role of Berberine in mitigating glucose metabolism, insulin resistance, lipid dysfunction, and liver inflammation in the progression of MAFLD by Clock genes Bmal1/Clock-mediated oxidative stress and circadian misalignment. This evidence concerns the gene BMAL1 and Insulin resistance.